Katie E. Lacy
St. John's Institute Of Dermatology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 23, 2026
Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 09, 2026
AllergoOncology: Emerging Translational and Clinical Significance of Basophils and Mast Cells in Cancer.
Journal: Clinical and translational allergy
Published: January 05, 2026
Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: a scoping review.
Journal: The British journal of dermatology
Published: August 15, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma.
Journal: Journal for immunotherapy of cancer
Published: May 13, 2025
Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha.
Journal: Allergy
Published: August 14, 2024
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.
Journal: Expert review of clinical immunology
Published: March 27, 2024
Identification and functional validation of a novel pathogenic POT1 germline variant p.G95V in familial melanoma.
Journal: JEADV clinical practice
Published: October 17, 2023
Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies.
Journal: Oncoimmunology
Published: October 10, 2022
Last Updated: 09/26/2026